Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX Showing element 2752 to 2801 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ASPARAGINYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.22) (ASPARAGINE-- TRNA LIGASE) (ASNRS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.117541\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.576375\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.203931468\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NARS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.099187\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.486671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.203807089\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PGAM5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT (BETA-ETF). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.429899\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.11091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.203655769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ETFB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2755\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.303744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.49161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.203634998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SSU72\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2756\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.153382\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.756695\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202699899\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATAD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACETYL-COA CARBOXYLASE 1 (EC 6.4.1.2) (ACC-ALPHA) [INCLUDES: BIOTIN CARBOXYLASE (EC 6.3.4.14)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.06806\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.26987\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202672931\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACACA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0721926\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.356265\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202637363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SAPS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPORULATION-INDUCED TRANSCRIPT 4-ASSOCIATED PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0957295\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.472418\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202637283\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SAPS3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE PROTEIN PHOSPHATASE 6 (EC 3.1.3.16) (PP6). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0987657\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.487402\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202637043\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP6C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0657247\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.324347\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202636991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SAPS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACETYL-COA CARBOXYLASE 2 (EC 6.4.1.2) (ACC-BETA) [INCLUDES: BIOTIN CARBOXYLASE (EC 6.3.4.14)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.938896\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.63429\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202597593\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACACB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SKELETAL MUSCLE LIM-PROTEIN 2 (SLIM 2) (FOUR AND A HALF LIM DOMAINS PROTEIN 3) (FHL-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.669714\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.30667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202534272\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FHL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SKELETAL MUSCLE LIM-PROTEIN 3 (SLIM 3) (LIM-DOMAIN PROTEIN DRAL) (FOUR AND A HALF LIM DOMAINS PROTEIN 2) (FHL-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.682678\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.37289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202401501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FHL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESTRADIOL 17 BETA-DEHYDROGENASE 4 (EC 1.1.1.62) (17-BETA-HSD 4) (17-BETA-HYDROXYSTEROID DEHYDROGENASE 4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.284553\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.40784\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202120269\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSD17B4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DEAD/H (ASP-GLU-ALA-ASP/HIS) BOX POLYPEPTIDE 11; DEAD/H BOX-11 (CHL1-RELATED HELICASE GENE-1); YEAST CHL1 HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.339171\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.6782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.20210404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DDX12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HELICASE (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.324046\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.60341\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.202098029\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 277. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0570468\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.282946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.20161727\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO ZINC FINGER PROTEIN 277. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0486609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.241353\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201617133\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LACTOYLGLUTATHIONE LYASE (EC 4.4.1.5) (METHYLGLYOXALASE) (ALDOKETOMUTASE) (GLYOXALASE I) (GLX I) (KETONE-ALDEHYDE MUTASE) (S-D-LACTOYLGLUTATHIONE METHYLGLYOXAL LYASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.570693\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.83362\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201400682\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GLO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAWD BINDING PROTEIN (UNKNOWN PROTEIN 32 FROM 2D-PAGE OF LIVER TISSUE). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0230825\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.11461\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.201400401\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PBLD\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LYSOPHOSPHOLIPASE I; LYSOPHOSPHOLIPASE 1; LYSOPHOSPHOLIPID-SPECIFIC LYSOPHOSPHOLIPASE; ACYL-PROTEIN THIOESTERASE-1. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
LYPLA1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DJ570F3.6 (NOVEL PROTEIN SIMILAR TO LYSOPHOSPHOLIPASE II (LYPLA2)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0202703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.100647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201399942\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LYSOPHOSPHOLIPASE II; ACYL-PROTEIN THIOESTERASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0206348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.102457\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201399612\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LYPLA2P1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORPHAN NUCLEAR RECEPTOR NURR1 (IMMEDIATE-EARLY RESPONSE PROTEIN NOT) (TRANSCRIPTIONALLY INDUCIBLE NUCLEAR RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.603026\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.99447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201379877\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR4A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEAR HORMONE RECEPTOR NOR-1 (NEURON-DERIVED ORPHAN RECEPTOR 1) (MITOGEN INDUCED NUCLEAR ORPHAN RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.515632\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.56143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201306302\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR4A3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORPHAN NUCLEAR RECEPTOR HMR (EARLY RESPONSE PROTEIN NAK1) (TR3 ORPHAN RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.508993\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.52853\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201299965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR4A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ELECTRON TRANSFER FLAVOPROTEIN ALPHA-SUBUNIT, MITOCHONDRIAL PRECURSOR (ALPHA-ETF). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.396527\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.97038\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201243922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ETFA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INSULIN GENE ENHANCER PROTEIN ISL-2 (ISLET-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.369521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.8374\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201110809\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ISL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.179735\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.894194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.201002243\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TARSL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN (EC 6.1.1.20) (PHENYLALANINE-- TRNA LIGASE BETA CHAIN) (PHERS) (HSPC173). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0470468\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.234118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.200953365\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FARSB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYNAPTOTAGMIN XII (SYTXII). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.236204\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.17564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.200915246\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SYT12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CA2+-DEPENDENT ENDOPLASMIC RETICULUM NUCLEOSIDE DIPHOSPHATASE; APYRASE; SOLUBLE CALCIUM-ACTIVATED NUCLEOTIDASE SCAN-1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.116337\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.580323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.200469394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CANT1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.469598\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.34488\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.200265259\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAHD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WD REPEAT AND FYVE DOMAIN CONTAINING 1 ISOFORM 1; PHOSPHOINOSITIDE-BINDING PROTEIN SR1; WD40 AND FYVE DOMAIN CONTAINING 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.447508\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.23848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199916014\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WDFY1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHENYLALANYL-TRNA SYNTHETASE ALPHA CHAIN (EC 6.1.1.20) (PHENYLALANINE- -TRNA LIGASE ALPHA CHAIN) (PHERS) (CML33). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0790566\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.39545\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.199915539\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
FARSA\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHENYLALANINE-TRNA SYNTHETASE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FARS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYPOSIS LOCUS PROTEIN 1 (TB2 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.195503\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.977987\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199903475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
REEP5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0519078\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.259665\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902952\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LYCAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2790\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLYPOSIS LOCUS PROTEIN 1-LIKE 1; LIKELY ORTHOLOG OF MOUSE POLYPOSIS LOCUS PROTEIN 1-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.150538\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.753056\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
REEP6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2791\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRAP/MEDIATOR COMPLEX COMPONENT TRAP25. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0557223\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.278747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902779\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MED30\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0536744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.268503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902422\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WDR32\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STROMAL INTERACTION MOLECULE 1 PRECURSOR. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0623579\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.311942\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.199902225\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
STIM1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN SPECIFIC, MITOCHONDRIAL PRECURSOR (EC 1.3.99.3) (MCAD). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
ACADM\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PAK 4 (EC 2.7.1.-) (P21-ACTIVATED KINASE 4) (PAK-4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.145818\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.729447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAK4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PAK 7 (EC 2.7.1.-) (P21-ACTIVATED KINASE 7) (PAK-7) (PAK-5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.193542\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.968184\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902085\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAK7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STROMAL INTERACTION MOLECULE 2 PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0487701\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.24397\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199902037\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STIM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WD REPEAT- AND FYVE DOMAIN-CONTAINING PROTEIN 2; WD40 AND FYVE DOMAIN CONTAINING 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.533046\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.66667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.199892\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WDFY2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATAXIN 2; OLIVOPONTOCEREBELLAR ATAXIA 2, AUTOSOMAL DOMINANT. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0572133\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.287777\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.198811232\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATAXIN 2 RELATED PROTEIN ISOFORM A; ATAXIN-2 DOMAIN PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.070265\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.353426\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.198811067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATXN2L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2801\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUMOR PROTEIN D53 (HD53) (D52-LIKE 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.142496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.71709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.198714248\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TPD52L1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots

- http://analysis.yellowcouch.org/